Antimicrobial Agents and Chemotherapy, February 2008, p. 811, Vol. 52, No. 2
0066-4804/08/$08.00+0 doi:10.1128/AAC.01429-07
| AUTHOR'S CORRECTION |
Global Pharmaceutical Research and Development, Abbott, Abbott Park, Illinois; Abbott Laboratories, Rungis, France; and Department of Virology, Pitié-Salpêtrière, Paris, France
Volume 51, no. 9, p. 3067-3074, 2007. Page 3068, column 1, line 6: The list of mutations should not include L24I.
Page 3068, column 1, line 10: The list of mutations assigned a weight of 3 should not include I47A.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |